“RENAL AND HEPATIC IMPAIRMENT BROUGHT ON BY CISPLATIN WITHOUT COMPROMISING ANTICANCER EFFICACY”. Romanian Journal of Diabetes, Nutrition and Metabolic Diseases, vol. 31, no. 1, Mar. 2024, pp. 394-06, https://jrdiabet.ro/index.php/RJDNMD/article/view/307.